NUVB
Nuvation Bio Inc.
Healthcare •
Biotechnology •
stocks •
XNYS
• usd
$5.86
$-0.04
(-0.68%)
Loading...
SMA 20: -
SMA 50: -
SMA 200: -
| General | Valuation | Profitability | Financial Health | Trading | Ownership |
|---|---|---|---|---|---|
| Market Cap | $2.01B | EPS (ttm) | $-0.49 | Current Price | $5.86 |
| Enterprise Value | $1.53B | Forward EPS | $0.55 | Previous Close | $5.90 |
| P/E Ratio | - | ROA | -24.82% | 52W High | $9.75 |
| Forward P/E | 10.65 | ROE | -52.49% | 52W Low | $1.54 |
| PEG Ratio | - | Gross Margin | 54.26% | 50 Day Avg | $7.61 |
| P/S Ratio | 75.11 | Operating Margin | -430.14% | 200 Day Avg | $4.11 |
| P/B Ratio | 6.16 | Profit Margin | - | Volume | 7.23M |
| EV/EBITDA | -6.61 | Current Ratio | 8.48 | Avg Volume | 7.42M |
| EV/Sales | 57.25 | Quick Ratio | 8.26 | Beta | 1.53 |
| Employees | 291.00 | Debt/Equity | 17.66 | Shares Outstanding | 341.83M |
| Sector | Healthcare | Total Debt | $57.55M | Float Shares | 231.59M |
| Industry | Biotechnology | Total Cash | $549.04M | Short Float | 22.79% |
| Optionable | Yes | Cash/Share | $1.60 | Short Ratio | 7.78 |
| Dividend Yield | - | Book Value/Share | $0.95 | % Held by Insiders | 19.05% |
| Target Price | $11.89 | Revenue (TTM) | $26.75M | % Held by Institutions | 66.29% |